Our Clients
Biotechnology and Pharmaceutical
Affinium Pharmaceuticals (Canada)
Apothogen
Axcan Pharmaceuticals (Canada)
Debiopharm (Switzerland)
Defender Pharmaceuticals
Galleon Pharmaceuticals
Glaxo, Inc.
Glaxo Wellcome, Inc.
Glaxo Wellcome plc (UK/global)
GlaxoSmithKline, Inc.
Grifols Inc
IntraBiotics
Ironshore Pharmaceuticals Inc
Karos Pharmaceuticals Inc.
KEJ Pharmaceuticals
Maabarot Products (Israel)
Matrivax
MicuRx Inc. (China)
Neuromed Development Inc
Nobelex Pharmaceuticals (Canada)
Oriel Therapeutics
Osmol Therapeutics
Oxford GlycoSciences Plc (UK)
Peninsula Pharmaceuticals
Percept Bio
Procter & Gamble Company
Protez Pharmaceuticals
Reliant Pharmaceuticals
Rhamnopharma Inc
Shire Pharmaceuticals
SmithKline Beecham
Spherix, Inc.
Synthon Pharmaceuticals (Netherlands)
Talecris Inc
United Therapeutics
ZWI Therapeutics
Device and Diagnostic Companies
Chem Glo LLC
Invitrox Inc.
Medtronics
Venture Capital, Investment Bankers and Financial Institutions
J.P. Morgan Partners
Perseus Soros
Thomas, Knight, Trent, King & Company
BioPharma has many contacts with VCs in US and Europe. In addition, we have supported due diligence activities for JP Morgan Partners and Perseus Soros.